Generic competition · all medicines · read 12 November 2026
Is there a generic of Nalmefene Hydrochloride, and who makes it?
Nalmefene Hydrochloride appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 2 generic makers listed as marketed across them. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 26.8 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Nalmefene Hydrochloride appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 2 generic makers listed as marketed across them.
- 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came 26.8 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Solution, Intramuscular, Intravenous, Subcutaneous
One to three generic makers listed
Every brand product here is listed as discontinued. 2 generic makers with 3 generic products listed as marketed; the first generic approval is dated 8 February 2022.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Knoa Pharma Llc | 8 February 2022 | 1 |
| Chengdu Shuode Pharmaceutical Co Ltd | 15 November 2023 | 2 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Intramuscular, Subcutaneous
Brand listed, no generic listed as marketed
Brand listed as marketed: Zurnai (Autoinjector). No generic is listed as marketed.
Patents and exclusivities still listed
- 7 August 2027Exclusivity NP Zurnai (Autoinjector)
- 5 November 2039Patent 11865112 drug product
- 5 November 2039Patent 11857547 drug product
Spray, Nasal
Brand listed, no generic listed as marketed
Brand listed as marketed: Opvee. No generic is listed as marketed.
Patents and exclusivities still listed
- 10 July 2038Patent 11458091 drug product
- 4 August 2042Patent 12290596
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.